Progressive familial intrahepatic cholestasis: A case with improvement in liver tests and growth following partial

Abraham Koshy1, Hariharan Ramesh, Pushpa Mahadevan

  • 1Department of Gastroenterology, Lakeshore Hospital and Research Centre, Kochi, India. koshyabe@yahoo.com

Insights

Progressive familial intrahepatic cholestasis (PFIC) in a child was successfully treated with partial external biliary diversion (PEBD). This treatment resolved jaundice and improved growth, even with existing liver fibrosis.

Area of Science:

  • Hepatology
  • Pediatric Gastroenterology
  • Surgical Innovation

Background:

  • Progressive familial intrahepatic cholestasis (PFIC) is a group of rare genetic disorders characterized by impaired bile flow.
  • Intrahepatic cholestasis can lead to severe liver damage, pruritus, and jaundice in affected children.
  • Current management options for PFIC are limited, often progressing to liver transplantation.

Observation:

  • A 2.5-year-old boy presented with a two-week history of jaundice and pruritus.
  • Investigations revealed elevated total bilirubin (23.4 mg/dL) with normal gamma-glutamyl transpeptidase.
  • Liver biopsy confirmed the diagnosis of PFIC, noting the presence of bridging fibrosis.

Findings:

  • The patient underwent a partial external biliary diversion (PEBD) procedure.
  • Post-surgery, the patient experienced complete resolution of pruritus.
  • Serum total bilirubin normalized, and growth parameters showed significant improvement within two months.

Implications:

  • This case is the first reported instance of PFIC treated with PEBD in India.
  • Partial external biliary diversion (PEBD) is a viable therapeutic option for PFIC, even in the presence of advanced fibrosis.
  • PEBD offers a potential alternative to liver transplantation for select PFIC patients, improving quality of life and clinical outcomes.